Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
15 rezultate
Treatment of pulmonary disease with protease inhibitors
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF THE INVENTION
The present invention relates to compositions and methods of treating pulmonary abnormalities such as adult respiratory distress syndrome (ARDS), neonatal respiratory distress syndrome (RDS), and/or sepsis syndrome, and the prevention thereof. More particularly, the invention
Therapeutic application of Kazal-type serine protease inhibitors
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
This is a national stage entry of PCT/EP2008/001009, filed Feb. 11, 2008, which claims priority to EP 07002903.8, filed Feb. 12, 2007, all of which are incorporated herein by reference.
The subject of the present invention is, in the most general aspect, the therapeutic application of the Kazal-type
Interleukin-1 beta converting enzyme like apoptotic protease-6
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Interleukin-1.beta. converting enzyme like apoptotic protease-6
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Interleukin-1.beta. converting enzyme like apoptotic protease-6
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Interleukin-1 beta converting enzyme like apoptotic protease-7
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND OF THE INVENTION
Apoptosis, or programmed cell death (PCD), is a genetically regulated mechanism with a central role in both metazoan development and homeostasis. (Raff, 1992; Steller, 1995). The cell death machinery is conserved throughout evolution (Vaux et al., 1994) and is composed of
Interleukin-1 .beta. converting enzyme like apoptotic protease-6
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Methods and compositions for inhibiting apoptosis using serine protease inhibitors
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
1. FIELD OF THE INVENTION
The present invention relates to compositions and methods useful in the inhibition of apoptosis. Likewise, the present invention relates to methods of treating diseases associated with excessive or unregulated apoptosis.
2. BACKGROUND OF THE INVENTION
Normal development,
Modified MT-SP1 proteases that inhibit complement activation
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
INCORPORATION BY REFERENCE OF SEQUENCE LISTING PROVIDED ELECTRONICALLY
An electronic version of the Sequence Listing is filed herewith, the contents of which are incorporated by reference in their entirety. The electronic file was created on May 9, 2014, is 2,308 kilobytes in size, and titled
Medicament for preventing and treating pseudomonas aeruginosa infections and method of its preparation
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
The present invention relates to a human .gamma.-globulin preparation used for prevention and treatment of diseases caused by infection with P. aeruginosa as well as to a process of producing the gamma globulin preparation.
P. aeruginosa has brought forward various problems in the medical field as a
Apparatus for the extracorporeal treatment of blood
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority from European Patent Application No. 13197790.2, filed on Dec. 17, 2013, the contents of this application are hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
State-of-the-art hospital treatment for
Endotoxin analysis
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF THE INVENTION
The present invention relates to the field of endotoxin analysis
BACKGROUND OF THE INVENTION
Endotoxin Analysis
Endotoxins are lipopolysaccharides (LPS) found in the outer membrane of the cell-wall of Gram-negative bacteria. Endotoxins comprise a lipid part, called lipid A, a
Method for treatment and prevention of physiological shock
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF THE INVENTION
The present invention is a method for the prevention and treatment physiologic shock involving the inhibition or removal of proteases in the small intestine and in circulation to prevent the generation of the mediators of shock. It is also a method for the identification of
4H-3,1-benzoxazin-4-one derivative
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
TECHNICAL FIELD
The present invention relates to a novel 4H-3,1-benzoxazin-4-one derivative and, more particularly, to 4H-3,1-benzoxazin-4-one derivatives having a serine protease inhibiting effect.
BACKGROUND ART
Proteases (proteolytic enzymes) present in a living body play a role in the
Methods and compositions for treating diabetes
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
1. FIELD OF THE INVENTION
The present invention relates to compositions and methods useful in the inhibition of apoptosis. Likewise, the present invention relates to methods of treating diseases associated with excessive or unregulated apoptosis.
2. BACKGROUND OF THE INVENTION
Normal development,
Cea mai completă bază de date cu plante medicinale susținută de știință
- Funcționează în 55 de limbi
- Cure pe bază de plante susținute de știință
- Recunoașterea ierburilor după imagine
- Harta GPS interactivă - etichetați ierburile în locație (în curând)
- Citiți publicațiile științifice legate de căutarea dvs.
- Căutați plante medicinale după efectele lor
- Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele
Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate
